{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:53:49Z","timestamp":1768287229978,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Public Welfare Projects for Chinese Medicine","award":["201107005"],"award-info":[{"award-number":["201107005"]}]},{"name":"National Public Welfare Projects for Chinese Medicine","award":["200807002"],"award-info":[{"award-number":["200807002"]}]},{"name":"Intervention for Polycystic Ovary Syndrome Based on Traditional Chinese Medicine Theory\u2014\u2018Tian Gui Disorder\u2019","award":["2011TD006"],"award-info":[{"award-number":["2011TD006"]}]},{"name":"National Clinical Trial Base in Chinese Medicine Special Projects","award":["JDZX2012036"],"award-info":[{"award-number":["JDZX2012036"]}]},{"name":"National Clinical Trial Base in Chinese Medicine Special Projects","award":["2015B009"],"award-info":[{"award-number":["2015B009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s40618-018-0953-6","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T04:51:56Z","timestamp":1538542316000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial"],"prefix":"10.1007","volume":"42","author":[{"given":"W.-Y.","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-S.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.-W.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"issue":"9588","key":"953_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370(9588):685\u2013697. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(07)61345-2","journal-title":"Lancet"},{"issue":"1","key":"953_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"L Bj\u00f6rndahl","year":"2004","unstructured":"Bj\u00f6rndahl L, Giwercman \u200eA, Tournaye H (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347","journal-title":"Hum Reprod"},{"issue":"39","key":"953_CR3","doi-asserted-by":"publisher","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","volume":"20","author":"CE Kelley","year":"2014","unstructured":"Kelley CE, Brown AJ, Diehl AM, Setji TL (2014) Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol 20(39):14172\u201314184. \n                    https:\/\/doi.org\/10.3748\/wjg.v20.i39.14172","journal-title":"World J Gastroenterol"},{"issue":"2","key":"953_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.fertnstert.2004.08.020","volume":"83","author":"JB Schwimmer","year":"2005","unstructured":"Schwimmer JB, Khorram O, Chiu V, Schwimmer WB (2005) Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 83(2):494\u2013497. \n                    https:\/\/doi.org\/10.1016\/j.fertnstert.2004.08.020","journal-title":"Fertil Steril"},{"issue":"12","key":"953_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","volume":"40","author":"ALL Rocha","year":"2017","unstructured":"Rocha ALL, Faria LC, Guimaraes TCM, Moreira GV, Candido AL, Couto CA, Reis FM (2017) Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. J Endocrinol Investig 40(12):1279\u20131288. \n                    https:\/\/doi.org\/10.1007\/s40618-017-0708-9","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"953_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33(6):981\u20131030. \n                    https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"issue":"4","key":"953_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7(4):219\u2013231. \n                    https:\/\/doi.org\/10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"issue":"32","key":"953_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1126\/scitranslmed.3001143","volume":"2","author":"MH Wu","year":"2010","unstructured":"Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C (2010) Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2(32):32\u201335. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3001143","journal-title":"Sci Transl Med"},{"issue":"7","key":"953_CR9","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/jc.2009-2698","volume":"95","author":"MJ Chen","year":"2010","unstructured":"Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS, Ho HN (2010) Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 95(7):3332\u20133341. \n                    https:\/\/doi.org\/10.1210\/jc.2009-2698","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"953_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H (2016) The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 22(6):687\u2013708. \n                    https:\/\/doi.org\/10.1093\/humupd\/dmw025","journal-title":"Hum Reprod Update"},{"issue":"10","key":"953_CR11","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1210\/jc.2011-1126","volume":"96","author":"LM Pastore","year":"2011","unstructured":"Pastore LM, Williams CD, Jenkins J, Patrie JT (2011) True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome. J Clin Endocrinol Metab 96(10):3143\u20133150. \n                    https:\/\/doi.org\/10.1210\/jc.2011-1126","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"953_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.fertnstert.2010.03.072","volume":"94","author":"M Bovey","year":"2010","unstructured":"Bovey M, Lorenc A, Robinson N (2010) Extent of acupuncture practice for infertility in the United Kingdom: experiences and perceptions of the practitioners. Fertil Steril 94(7):2569\u20132573. \n                    https:\/\/doi.org\/10.1016\/j.fertnstert.2010.03.072","journal-title":"Fertil Steril"},{"issue":"9","key":"953_CR13","doi-asserted-by":"publisher","first-page":"E934","DOI":"10.1152\/ajpendo.00039.2013","volume":"304","author":"J Johansson","year":"2013","unstructured":"Johansson J, Redman L, Veldhuis PP, Sazonova A, Labrie F, Holm G, Johannsson G, Stener-Victorin E (2013) Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 304(9):E934\u2013E943. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00039.2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"953_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ctim.2014.06.001","volume":"22","author":"CA Smith","year":"2014","unstructured":"Smith CA, Armour M, Betts D (2014) Treatment of women\u2019s reproductive health conditions by Australian and New Zealand acupuncturists. Complement Ther Med 22(4):710\u2013718. \n                    https:\/\/doi.org\/10.1016\/j.ctim.2014.06.001","journal-title":"Complement Ther Med"},{"issue":"5","key":"953_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1467-789X.2011.00979.x","volume":"13","author":"Y Sui","year":"2012","unstructured":"Sui Y, Zhao HL, Wong VC, Brown N, Li XL, Kwan AK, Hui HL, Ziea ET, Chan JC (2012) A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obes Rev 13(5):409\u2013430. \n                    https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00979.x","journal-title":"Obes Rev"},{"issue":"4","key":"953_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/acupmed-2016-011074","volume":"34","author":"B Martinez","year":"2016","unstructured":"Martinez B, Peplow PV (2016) Treatment of insulin resistance by acupuncture: a review of human and animal studies. Acupunct Med 34(4):310\u2013319. \n                    https:\/\/doi.org\/10.1136\/acupmed-2016-011074","journal-title":"Acupunct Med"},{"issue":"24","key":"953_CR17","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1001\/jama.2017.7217","volume":"317","author":"XK Wu","year":"2017","unstructured":"Wu XK, Stener-Victorin E, Kuang HY, Ma HL, Gao JS, Xie LZ, Hou LH, Hu ZX, Shao XG, Ge J, Zhang JF, Xue HY, Xu XF, Liang RN, Ma HX, Yang HW, Li WL, Huang DM, Sun Y, Hao CF, Du SM, Yang ZW, Wang X, Yan Y, Chen XH, Fu P, Ding CF, Gao YQ, Zhou ZM, Wang CC, Wu TX, Liu JP, Ng EHY, Legro RS, Zhang H (2017) Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial. JAMA 317(24):2502\u20132514. \n                    https:\/\/doi.org\/10.1001\/jama.2017.7217","journal-title":"JAMA"},{"key":"953_CR18","doi-asserted-by":"publisher","first-page":"527303","DOI":"10.1155\/2013\/527303","volume":"2013","author":"H Kuang","year":"2013","unstructured":"Kuang H, Li Y, Wu X, Hou L, Wu T, Liu J, Ng EH, Stener-Victorin E, Legro RS, Zhang H (2013) Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial. Evid Based Complement Altern Med (ECAM) 2013:527303. \n                    https:\/\/doi.org\/10.1155\/2013\/527303","journal-title":"Evid Based Complement Altern Med (ECAM)"},{"issue":"2","key":"953_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","volume":"51","author":"G Targher","year":"2016","unstructured":"Targher G, Rossini M, Lonardo A (2016) Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? Endocrine 51(2):211\u2013221. \n                    https:\/\/doi.org\/10.1007\/s12020-015-0640-8","journal-title":"Endocrine"},{"issue":"4","key":"953_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.diabet.2014.04.006","volume":"40","author":"MJ Lee","year":"2014","unstructured":"Lee MJ, Jung CH, Kang YM, Hwang JY, Jang JE, Leem J, Park JY, Kim HK, Lee WJ (2014) Serum bilirubin as a predictor of incident metabolic syndrome: a 4-year retrospective longitudinal study of 6205 initially healthy Korean men. Diabetes Metab 40(4):305\u2013309. \n                    https:\/\/doi.org\/10.1016\/j.diabet.2014.04.006","journal-title":"Diabetes Metab"},{"key":"953_CR21","doi-asserted-by":"publisher","first-page":"9621615","DOI":"10.1155\/2017\/9621615","volume":"2017","author":"XH Li","year":"2017","unstructured":"Li XH, Lin HY, Guan LY, Peng H, Wen MM, Cao YQ, Jiang XY, Wang YB (2017) Direct bilirubin levels and risk of metabolic syndrome in healthy Chinese men. Biomed Res Int 2017:9621615. \n                    https:\/\/doi.org\/10.1155\/2017\/9621615","journal-title":"Biomed Res Int"},{"issue":"8","key":"953_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/met.2017.0064","volume":"15","author":"R Kawamoto","year":"2017","unstructured":"Kawamoto R, Ninomiya D, Senzaki K, Kumagi T (2017) Alanine aminotransferase and total bilirubin are synergistically associated with metabolic syndrome among middle-aged and elderly Japanese women. Metab Syndr Relat Disord 15(8):407\u2013415. \n                    https:\/\/doi.org\/10.1089\/met.2017.0064","journal-title":"Metab Syndr Relat Disord"},{"key":"953_CR23","doi-asserted-by":"publisher","first-page":"6873197","DOI":"10.1155\/2017\/6873197","volume":"2017","author":"HS Lee","year":"2017","unstructured":"Lee HS, Park T (2017) Pathway-driven approaches of interaction between oxidative balance and genetic polymorphism on metabolic syndrome. Oxid Med Cell Longev 2017:6873197. \n                    https:\/\/doi.org\/10.1155\/2017\/6873197","journal-title":"Oxid Med Cell Longev"},{"issue":"Suppl 3","key":"953_CR24","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","volume":"27","author":"GS Hotamisligil","year":"2003","unstructured":"Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53\u2013S55. \n                    https:\/\/doi.org\/10.1038\/sj.ijo.0802502","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 1:s3\u2013105","key":"953_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5604\/01.3001.0010.5672","volume":"16","author":"JA Gonzalez-Regueiro","year":"2017","unstructured":"Gonzalez-Regueiro JA, Moreno-Castaneda L, Uribe M, Chavez-Tapia NC (2017) The role of bile acids in glucose metabolism and their relation with diabetes. Ann Hepatol 16(Suppl 1:s3\u2013105):16\u201321. \n                    https:\/\/doi.org\/10.5604\/01.3001.0010.5672","journal-title":"Ann Hepatol"},{"issue":"3","key":"953_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/humrep\/den433","volume":"24","author":"AJ Goverde","year":"2009","unstructured":"Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ (2009) Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod 24(3):710\u2013717. \n                    https:\/\/doi.org\/10.1093\/humrep\/den433","journal-title":"Hum Reprod"},{"issue":"4","key":"953_CR27","first-page":"783","volume":"91","author":"C Singh","year":"1996","unstructured":"Singh C, Bishop P, Willson R (1996) Extreme hyperbilirubinemia associated with the use of anabolic steroids, health\/nutritional supplements, and ethanol: response to ursodeoxycholic acid treatment. Am J Gastroenterol 91(4):783\u2013785","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"953_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12328-014-0484-4","volume":"7","author":"A Okano","year":"2014","unstructured":"Okano A, Ohana M, Kusumi F (2014) Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer. Clin J Gastroenterol 7(3):278\u2013282. \n                    https:\/\/doi.org\/10.1007\/s12328-014-0484-4","journal-title":"Clin J Gastroenterol"},{"issue":"10","key":"953_CR29","doi-asserted-by":"publisher","first-page":"E1645","DOI":"10.1210\/jc.2011-1093","volume":"96","author":"M Aubuchon","year":"2011","unstructured":"Aubuchon M, Kunselman AR, Schlaff WD, Diamond MP, Coutifaris C, Carson SA, Steinkampf MP, Carr BR, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Myers ER, Legro RS (2011) Metformin and\/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. J Clin Endocrinol Metab 96(10):E1645\u2013E1649. \n                    https:\/\/doi.org\/10.1210\/jc.2011-1093","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"953_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.26909","volume":"60","author":"U Beuers","year":"2014","unstructured":"Beuers U, Kremer AE, Bolier R, Elferink RP (2014) Pruritus in cholestasis: facts and fiction. Hepatology 60(1):399\u2013407. \n                    https:\/\/doi.org\/10.1002\/hep.26909","journal-title":"Hepatology"},{"issue":"4","key":"953_CR31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/hep.26617","volume":"59","author":"V Geenes","year":"2014","unstructured":"Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case\u2013control study. Hepatology 59(4):1482\u20131491. \n                    https:\/\/doi.org\/10.1002\/hep.26617","journal-title":"Hepatology"},{"issue":"2","key":"953_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40(2):467\u2013474. \n                    https:\/\/doi.org\/10.1002\/hep.20336","journal-title":"Hepatology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0953-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T23:26:21Z","timestamp":1570058781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0953-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0953-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors had no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}